Cytosorbents Corp Files 8-K
Ticker: CTSO · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-disclosure, exhibits
TL;DR
Cytosorbents Corp filed an 8-K on April 15th, reporting an event from April 14th. Check for Reg FD and financial updates.
AI Summary
Cytosorbents Corporation filed an 8-K on April 15, 2025, reporting an event on April 14, 2025. The filing is categorized under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as MedaSorb Technologies CORP and GILDER ENTERPRISES INC, is incorporated in Delaware and headquartered in Princeton, New Jersey.
Why It Matters
This 8-K filing indicates a regulatory disclosure and potential financial updates from Cytosorbents Corporation, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for regulatory disclosure and exhibits, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- MedaSorb Technologies CORP (company) — Former company name
- GILDER ENTERPRISES INC (company) — Former company name
- April 14, 2025 (date) — Earliest event date
- April 15, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Princeton, New Jersey (location) — Principal executive offices
FAQ
What specific event occurred on April 14, 2025, that necessitated this 8-K filing?
The filing does not specify the exact event, only that it occurred on April 14, 2025, and falls under Regulation FD Disclosure and Financial Statements and Exhibits.
What is the primary purpose of this 8-K filing for Cytosorbents Corporation?
The primary purpose is for Regulation FD Disclosure and to file Financial Statements and Exhibits, as indicated in the filing information.
When was Cytosorbents Corporation incorporated and where are its principal executive offices located?
Cytosorbents Corporation was incorporated in Delaware and its principal executive offices are located at 305 College Road East, Princeton, New Jersey 08540.
What were the previous names of Cytosorbents Corporation?
The company was formerly known as MedaSorb Technologies CORP and GILDER ENTERPRISES INC.
What is the SEC file number and Commission File Number for Cytosorbents Corporation?
The SEC file number is 001-36792, and the Commission File Number is also 001-36792.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Cytosorbents Corp (CTSO).